Wed, 26 Feb 2020 18:21:09: Former FDA chief Gottlieb under consideration as potential coronavirus 'czar': Politico

Wed, 26 Feb 2020 15:49:58: Amarin aims for Vascepa boom with doubled sales force nearly in place

Wed, 26 Feb 2020 15:46:47: FDA spanks KVK Tech over impurities in ADHD drug

Wed, 26 Feb 2020 15:30:48: NICE rejects Roche's new cancer med Polivy on lack of long-term evidence

Wed, 26 Feb 2020 15:17:17: Bayer picks an unconventional board chair as Wenning bails amid Roundup legal woes

Wed, 26 Feb 2020 14:48:06: Chinese heparin maker tried to sneak proof of its unapproved APIs out the back door

Wed, 26 Feb 2020 14:41:44: Endo touts financial 'flexibility' as massive opioid settlements mount industrywide

Tue, 25 Feb 2020 21:50:10: Mallinckrodt places hopes on 'modernized' Acthar with generic unit facing bankruptcy

Tue, 25 Feb 2020 16:21:56: ICER comes around on Allergan, Biohaven migraine meds. Lilly's? Not so much

Tue, 25 Feb 2020 15:33:43: AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik

Tue, 25 Feb 2020 15:25:56: Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round

Mon, 24 Feb 2020 23:34:17: Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit

Mon, 24 Feb 2020 19:25:33: Novartis' hot new eye drug Beovu tied to potential vision loss: experts

Mon, 24 Feb 2020 16:41:56: Sanofi to create massive standalone API producer by melding 6 sites in Europe; IPO to come

Mon, 24 Feb 2020 15:31:27: Biocon confident of approval for Lantus copy after Malaysia plant inspected by FDA a 3rd time

Mon, 24 Feb 2020 15:27:18: Eli Lilly's Trulicity nabs novel CV approval in patients with or without established disease

Mon, 24 Feb 2020 14:35:47: Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics

Mon, 24 Feb 2020 14:19:57: FiercePharmaPolitics—Grassley pushes for Senate drug pricing bill to pass by May

Sun, 23 Feb 2020 23:27:04: McCann Health taps New York consumer veteran for new global health creative director

Sun, 23 Feb 2020 14:28:32: Allergan accused of misleading CoolTone marketing in new lawsuit from BTL

Fri, 21 Feb 2020 22:15:51: Esperion scores FDA nod for cholesterol-buster Nexletol

Fri, 21 Feb 2020 20:29:02: Lundbeck's FDA nod for Vyepti piles even more competition on crowded migraine prevention field

Fri, 21 Feb 2020 16:20:50: 'Boring is good,' Teva CEO Schultz says amid push to hit targets, remove risk

Fri, 21 Feb 2020 15:53:21: Puma Biotech's Nerlynx remains a dud. Will a breast cancer expansion turn things around?

Fri, 21 Feb 2020 14:20:43: Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court